PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0020538|hypertension |
| Sentences | 13 |
| PubMedID- 25788998 | Based on these symptoms, an initial diagnosis of pulmonary thromboembolism with severe pulmonary hypertension and a minor pericardial effusion was determined. |
| PubMedID- 22943645 | Objective: to evaluate the incidence and predictive factors of chronic thromboembolic pulmonary hypertension (cteph) in patients with acute pulmonary thromboembolism (pte). |
| PubMedID- 24702799 | The best therapeutic option for chronic thromboembolic pulmonary hypertension due to an infectious thromboembolic event is highly debatable and the results are poor. |
| PubMedID- 22837856 | Pulmonary hypertension as a result of chronic thromboembolic disease (cteph) is potentially curable with pulmonary endarterectomy surgery. |
| PubMedID- 25327600 | Conclusion: pat is not uncommon in nvaf patients, risk factors for pat in nvaf patients are vascular disease, advanced age, hypertension, history of stroke/tia/arterial thromboembolism and congestive heart failure. |
| PubMedID- 23457622 | Potential covariates were assessed based on known associations with ventricular size and heart disease, including demographics and anthropometric variables, as well as variables reflecting comorbidities and other characteristics (including systolic and diastolic blood pressure, hypertension, diabetes mellitus, history of venous thromboembolism, self-reported intentional exercise, use of anti-hypertensives, aspirin, statins, lipid-lowering therapy, hormone replacement therapy, hga1c, total cholesterol, low- and high-density lipoproteins, triglycerides, fasting glucose and insulin levels, serum il-6, c-reactive protein (crp), serum creatinine). |
| PubMedID- 25825696 | By using the rush protocol, our examiners successfully diagnosed two patients with cardiac tamponade, two with extensive acute pulmonary thromboembolism, three with right heart failure related to secondary pulmonary hypertension (in the context of chronic pulmonary thromboembolic disease in two cases, and extensive pulmonary parenchymal disease in the other) two of three with pneumothorax. |
| PubMedID- 21883481 | Eculizumab has shown significant efficacy in controlled studies, with a marked decrease in anemia, fatigue, transfusion requirements, renal impairment, pulmonary hypertension, and risk of severe thromboembolic events, ultimately resulting in improving quality of life and survival. |
| PubMedID- 23762560 | Thrombophilia may predispose to the development of superficial and deep lower limb venous reflux as a result of macrovascular thromboembolic disease, with subsequent venous hypertension, skin changes, and ultimately venous ulceration. |
| PubMedID- 25796019 | Association of thromboembolism risk factors' with pulmonary hypertension were studied at the beginning of the study and six months after the treatment then the results of two groups were compared. |
| PubMedID- 24826251 | In the case of our patient, the development of pulmonary hypertension due to chronic thromboembolism was a complication factor and certainly an occurrence that would be responsible for a worse outcome. |
| PubMedID- 23781572 | Surgical treatment is recommended in case of chronic pulmonary hypertension, due to thromboembolic disease. |
| PubMedID- 21750555 | Adverse drug reactions (hypertension, proteinuria, thromboembolism, impaired wound healing) seen with other anti-angiogenic agents such as bevacizumab were not observed in intetumumab-treated patients. |
Page: 1